Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin to Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01127893
What this trial is testing

Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis

Who this might be right for
Osteoarthritis
Pfizer 1
Testing effectiveness (Phase 2)Study completedNCT00076752
What this trial is testing

Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Ended earlyNCT03943147
What this trial is testing

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 16
Testing effectiveness (Phase 2)Ended earlyNCT04108858
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8HER2-Positive Breast CarcinomaMetastatic Breast Carcinoma
National Cancer Institute (NCI) 2
Large-scale testing (Phase 3)Ended earlyNCT01840085
What this trial is testing

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

Who this might be right for
Diabetic Foot Ulcer
Integra LifeSciences Corporation 261
Early research (Phase 1)UnknownNCT00701987
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma

Who this might be right for
Melanoma
Advanced Life Sciences, Inc. 12
Large-scale testing (Phase 3)Looking for participantsNCT06822478
What this trial is testing

Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.

Who this might be right for
Leishmaniasis, Cutaneous
Universidad de Antioquia 96
Testing effectiveness (Phase 2)Looking for participantsNCT07565285
What this trial is testing

The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma

Who this might be right for
Melanoma Stage III
Primmune Therapeutics, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT04194814
What this trial is testing

Skin bioMARkers for Atopic Eczema Therapy Evaluation

Who this might be right for
Atopic Eczema/Dermatitis (Non-Specific)
Sheffield Teaching Hospitals NHS Foundation Trust 37
Testing effectiveness (Phase 2)Study completedNCT06694038
What this trial is testing

Needle-Knife Fistulotomy Vs. Standard Cannulation Trial

Who this might be right for
Biliary Obstruction Due to Common Bile Duct StoneMalignant Bile Duct Obstruction
Thomas Jefferson University 186
Not applicableStudy completedNCT03981926
What this trial is testing

Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis EczemaAtopic DermatitisEczema
University of Southern California 300
Not applicableUnknownNCT06471452
What this trial is testing

To Live Better After Breast Cancer Treatment

Who this might be right for
Breast Cancer Survivorship
Karolinska Institutet 40
Not applicableStudy completedNCT02852148
What this trial is testing

ACTICOAT™ for the Treatment of Burns and Chronic Wounds

Who this might be right for
Wounds and InjuriesBurnsPressure Ulcer+1 more
Smith & Nephew, Inc. 25
Not applicableEnded earlyNCT04462055
What this trial is testing

Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Food Allergy
UMC Utrecht 3
Not applicableActive Not RecruitingNCT07588243
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth

Who this might be right for
Androgenic Alopecia
CynosureLutronic 44
Early research (Phase 1)Study completedNCT05114889
What this trial is testing

Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Biosion, Inc. 54
Testing effectiveness (Phase 2)UnknownNCT04720768
What this trial is testing

Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE

Who this might be right for
MelanomaMetastasis
Peter MacCallum Cancer Centre, Australia 78
Testing effectiveness (Phase 2)Study completedNCT00820950
What this trial is testing

Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Incyte Corporation 29
Testing effectiveness (Phase 2)Study completedNCT02187991
What this trial is testing

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

Who this might be right for
Breast CancerBreast CarcinomaBreast Tumors+1 more
US Oncology Research 169
Not applicableWithdrawnNCT06036485
What this trial is testing

Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures

Who this might be right for
Leg Ulcer
Insel Gruppe AG, University Hospital Bern
Next Page